Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.180
-0.030 (-2.48%)
Jul 6, 2026, 2:04 PM EDT - Market open
Creative Medical Technology Holdings Employees
Creative Medical Technology Holdings had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$750
Profits / Employee
-$1,440,497
Market Cap
4.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| GeoVax Labs | 19 |
| FibroBiologics | 15 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| 60 Degrees Pharmaceuticals | 3 |
CELZ News
- 5 days ago - Creative Medical Technology Holdings Issues Mid-Year Update - GlobeNewsWire
- 6 days ago - Creative Medical announces agreements for exercise of warrants for $4.5M - TheFly
- 6 days ago - Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds - GlobeNewsWire
- 6 days ago - Why Did Penny Stock Creative Medical Technology Holdings (CELZ) Rocket Higher Today? - TipRanks
- 10 days ago - Creative Medical files to sell 3.05M shares of common stock - TheFly
- 14 days ago - Creative Medical expands ADAPT trial under new FDA clearance - TheFly
- 14 days ago - Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain - GlobeNewsWire
- 20 days ago - Creative Medical launches national veteran data collection for Project PHOENIX - TheFly